47 recruiting, 20 not yet recruiting, 18 completed, 8 active not recruiting. 44 Not applicable, 14 Phase 4, 3 Phase 2, 1 Phase 1, 1 Phase 3.
Follow Coronary Arterial Disease (CAD): new trials by email Literature Review of Coronary Arterial Disease (CAD) trials Research Report on Coronary Arterial Disease (CAD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reconsidering Long-Term Apirin in the Elderly in Secondary Prevention of Coronary Artery Disease Norway Discontinuation of aspirin (ATC-code B01AC06 and N02BA01) - Coronary Arterial Disease (CAD) | Phase 4 | Not yet recruiting | Vestre Viken Hospital Trust | 7000 | 2027-02-01 | 2026-10-02 |
| GOT VOICE Feasibility With In-Person Group Singing In-Person Group Singing, instructional sing-along video series, Weekly health education - Elderly, Coronary Arterial Disease (CAD) | Not applicable | Not yet recruiting | Medical College of Wisconsin | 48 | 2026-10-31 | 2026-10-29 |
| Non-Invasive Follow-Up of Patients With Coronary Artery Disease Treated With Drug-Coated Balloon PCI Using CT-Derived Fractional Flow Reserve Coronary Arterial Disease (CAD), Acute Coronary Syndromes (ACS) | Not yet recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 150 | 2026-09-01 | 2026-09-16 | |
| Branching Scenario-Based Education in Coronary Artery Disease Virtual Reality-Based Branching Scenario Education, Tablet-Based Branching Scenario Education - Coronary Arterial Disease (CAD) | Not applicable | Not yet recruiting | Abant Izzet Baysal University | 54 | 2026-09-01 | 2026-09-17 |
| Spectral and Ultra High Resolution CT Systems for Non-Invasive Detection of Myocardial Ischemia: Stress CT Perfusion VS. FFR-CT FFR-CT, CT Angiography | Not yet recruiting | IRCCS San Raffaele | 142 | 2026-09-01 | 2026-09-21 | |
| OPN Balloon for SAFE Recanalization of Calcified Coronary Lesions non compliant balloon - Coronary Arterial Disease (CAD), In Stent Restenosis | Recruiting | Minneapolis Heart Institute Foundation | 300 | 2026-08-01 | 2026-08-10 | |
| Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease Edoxaban, Apixaban - Atrial Fibrillation (AF), Coronary Arterial Disease (CAD) | Phase 4 | Recruiting | Samsung Medical Center | 3000 | 2026-07-20 | 2026-08-10 |
| Study Evaluating the Effects of Red Grape Juice Consumption on Metabolism in Men With Coronary Artery Disease Red Grape Juice - Coronary Arterial Disease (CAD) | Not applicable | Recruiting | University of Sao Paulo General Hospital | 50 | 2026-07-10 | 2026-08-28 |
| Evaluation of Calcified Coronary Lesion Preparation With the Naviscore Scoring Balloon Scoring Balloon PTCA Catheter, Non-Compliant (NC) Angioplasty Balloon - Coronary Arterial Disease (CAD), Calcific Coronary Arteriosclerosis | Not applicable | Not yet recruiting | University of Mons | 200 | 2026-07-01 | 2026-06-16 |
| AVS Pulse Intravascular Lithotripsy™ (Pulse IVL™) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling for Coronary Artery Disease Pulse Intravascular Lithotripsy (Pulse IVL) - Coronary Arterial Disease (CAD) | Not applicable | Recruiting | Amplitude Vascular Systems, Inc. | 15 | 2026-05-08 | 2026-08-17 |
| The Bridging Antiplatelet Therapy With Cangrelor 2 Study Cangrelor - Coronary Arterial Disease (CAD) | Phase 4 | Recruiting | University of Florida | 50 | 2026-02-18 | 2026-05-05 |
| Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease Coronary Arterial Disease (CAD), NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI) | Recruiting | Fundación Interhospitalaria para la Investigación Cardiovascular FIC | 1118 | 2026-01-05 | 2026-03-03 | |
| External Validation of Ischemia and Hemorrhage Risk Models in Patients With Coronary Heart Disease Ischemic risk and bleeding risk model - Coronary Arterial Disease (CAD) | Not yet recruiting | Beijing Hospital | 5000 | 2026-01-01 | 2025-12-19 | |
| Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease atenolol, Metoprolol tartrate, Ivabradine - Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD) | Phase 2 / Phase 3 | Enrolling by invitation | Gødstrup Hospital | 350 | 2025-12-15 | 2025-12-17 |
| Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE) Prasugrel 5 mg, Dual Antiplatelet (DAPT) Therapy - Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI) | Phase 4 | Recruiting | J.P.S Henriques | 300 | 2025-11-13 | 2026-03-04 |
| OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure Percutaneous coronary intervention with protocolized implantation of a second generation thin-strut bioresorbable scaffold guided by intracoronary imaging - Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI) | Recruiting | Albert Schweitzer Ziekenhuis, Netherlands | 117 | 2025-11-04 | 2026-05-18 | |
| Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques PCI strategy, OMT strategy - Coronary Arterial Disease (CAD), Vulnerable Coronary Plaques | Phase 4 | Recruiting | Beijing Anzhen Hospital | 2190 | 2025-11-03 | 2026-10-16 |
| Feasibility Study of the Supira System in Patients Undergoing HRPCI With Support Beyond the PCI Procedure Supira System - Heart Disease, Coronary Arterial Disease (CAD) | Not applicable | Recruiting | Supira Medical | 45 | 2025-10-12 | 2026-02-17 |
| Shockwave Intervention for Enhanced Wound Healing in No-touch Pedicle Saphenous Vein Graft Harvesting for Coronary Artery Bypass Grafting Shockwave treatment, Sham treatment - Coronary Arterial Disease (CAD) | Not applicable | Recruiting | Medical University Innsbruck | 120 | 2025-10-03 | 2025-12-23 |
| The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms Semaglutide 1.0 mg, Semaglutide 0.5 mg - Glucagon-Like Peptide-1 Receptor Agonists, Type 2 Diabetes | Phase 4 | Not yet recruiting | Taipei Veterans General Hospital, Taiwan | 60 | 2025-10-01 | 2025-07-18 |
Showing 20 of 101. Sign in to see all of them.
Coronary Artery Disease (25) · Acute Coronary Syndrome (9) · Heart Diseases (5) · Myocardial Ischemia (5) · Angina, Stable (4) · Coronary Disease (4) · Angina Pectoris (3) · Diabetes Mellitus (3) · Heart Failure (3) · Myocardial Infarction (3) · Renal Insufficiency, Chronic (3) · Stroke (3) · Aortic Valve Disease (2) · Arterial Occlusive Diseases (2) · Atherosclerosis (2)
Cardiovascular Diseases (53) · Vascular Diseases (50) · Heart Diseases (47) · Myocardial Ischemia (41) · Arterial Occlusive Diseases (27) · Arteriosclerosis (27) · Coronary Disease (26) · Pathological Conditions, Signs and Symptoms (17) · Pathologic Processes (10) · Metabolic Diseases (8) · Nutritional and Metabolic Diseases (8) · Signs and Symptoms (7) · Neurologic Manifestations (6) · Glucose Metabolism Disorders (5) · Pain (5)
Percutaneous Coronary Intervention (4) · Prasugrel Hydrochloride (4) · Clopidogrel (3) · Coronary Angiography (3) · Sodium Chloride (3) · Aspirin (2) · Cardiac Rehabilitation (2) · Coronary Artery Bypass (2) · Metoprolol (2) · 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1) · Angiography (1) · Angioplasty, Balloon (1) · Atenolol (1) · Atorvastatin (1) · Blood Specimen Collection (1)
University of Florida (4) · University of Sao Paulo General Hospital (3) · Beijing Hospital (2) · Chang Gung University of Science and Technology (2) · China National Center for Cardiovascular Diseases (2) · Genoss Co., Ltd. (2) · Kutahya Health Sciences University (2) · Tampere Heart Hospital (2) · University Medical Center Ho Chi Minh City (UMC) (2) · VZW Cardiovascular Research Center Aalst (2) · Aalborg University Hospital (1) · Abant Izzet Baysal University (1) · Abcentra (1) · Abdulgani Orhun YENİGÜN (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)
China (16) · Turkey (Türkiye) (13) · United States (11) · Spain (8) · Italy (6) · South Korea (5) · Belgium (4) · Denmark (4) · Portugal (4) · United Kingdom (4) · Brazil (3) · Romania (3) · Sweden (3) · Taiwan (3) · Australia (2)
Dominick J Angiolillo, MD, PhD (2) · Adela Maria Gomez Gonzalez, PhD, Medical Doctor (1) · Antonio Carlos Palandri Chagas (1) · Antonio Serra (1) · Anwar Suhaimi (1) · Bhavin Oza, Bsc (1) · Bo Luan, Phd (1) · Carlos Collet, MD (1) · Cheng Zhang, Phd (1) · Ching-Ching Tsai, Associated Professor (1) · Chuanyu Gao, Phd (1)
PMID 10805047, PMID 12595539, PMID 17347049, PMID 17562958, PMID 18288753, PMID 20464430, PMID 21670242, PMID 23460596, PMID 24241342, PMID 24852804, PMID 25628572, PMID 25819177, PMID 26585621, PMID 26935262, PMID 27536731, PMID 28183511, PMID 28791567, PMID 29268891, PMID 29891620, PMID 29897428, PMID 29957595, PMID 30165617, PMID 30328257, PMID 31813921, PMID 31876045, PMID 31904726, PMID 32139218, PMID 32310133, PMID 32368683, PMID 32855116, PMID 32944327, PMID 33175990, PMID 33714389, PMID 34233996, PMID 34317190, PMID 34531027, PMID 34939921, PMID 35002770, PMID 35034351, PMID 35266173, PMID 35595672, PMID 35595673, PMID 35861828, PMID 35911661, PMID 36389323, PMID 36876735, PMID 37029020, PMID 37164599, PMID 37164600, PMID 37634149
2023 (1), 2025 (1), R34AT013239 (1)